Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See moreOpen | $12.81 |
Previous Close | $12.78 |
Day Range | $12.66-$12.81 |
52W Range | $7.02-$15.42 |
Market Cap | $4B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $3B |
Revenue Growth (YoY) | 3.9% |
Gross Profit (12 Mos) | $1.1B |
Diluted EPS | $0.37 |
News
See moreYahoo Finance • 4 days ago
Amneal Pharmaceuticals beats top-line and bottom-line estimates; reaffirms FY26 outlook
Yahoo Finance • 7 days ago
Amneal Pharmaceuticals Kashiv Deal Puts Biosimilar Growth And Valuation In Focus
Yahoo Finance • 11 days ago
UBS Initiates Coverage of Amneal Pharmaceuticals (AMRX) With a Bullish Outlook
Yahoo Finance • 18 days ago
Amneal Pharmaceuticals to Buy Kashiv BioSciences, Touts Strong Preliminary Q1 Results and Biosimilar Push
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,700 |